NeuBase Therapeutics, Inc.NBSE
Market cap
$1.41M
P/E ratio
| 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | |
| Return on Assets | -59 | -122.1 | -16.3 | -10 | -17.5 | -83 | -66.9 | -223.2 | -74 | -51.5 | -69.7 |
| Return on equity (%) | - |
| 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | |
| Return on Assets | -59 | -122.1 | -16.3 | -10 | -17.5 | -83 | -66.9 | -223.2 | -74 | -51.5 | -69.7 |
| Return on equity (%) | - |